Over the past 30 years, conventional IGRT has introduced many life-saving developments, yet poor soft tissue contrast, the use of surrogates to identify anatomy, and having no real-time imaging during beam-on have often constrained clinical potential.
Combining the latest innovations in precision radiation delivery with ground-breaking MR image guidance and on-table adaptive therapy, it’s time for the next big advance in radiation oncology.
The future of radiation therapy is here.
First pioneered by ViewRay in 2012, MRI-Guided ROAR™ represents a new paradigm in the treatment of cancer, providing clinicians with the ability to improve targeting precision and thus deliver higher, and potentially more effective, radiation doses.
Please log in to access the ViewRay Customer Portal. To request access, please click here. Request will be reviewed within 2 business days.